These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3373225)

  • 1. On the stereochemistry of fecapentaene-12.
    Kingston DG; Piccariello T; Duh CY; Govindan SV; Wilkins TD; van Tassell RL; Van der Gen A; De Wit PP; Van der Steeg M
    J Nat Prod; 1988; 51(1):176-9. PubMed ID: 3373225
    [No Abstract]   [Full Text] [Related]  

  • 2. Structures of fecapentaenes, the mutagens of bacterial origin isolated from human feces.
    Gupta I; Baptista J; Bruce WR; Che CT; Furrer R; Gingerich JS; Grey AA; Marai L; Yates P; Krepinsky JJ
    Biochemistry; 1983 Jan; 22(2):241-5. PubMed ID: 6824628
    [No Abstract]   [Full Text] [Related]  

  • 3. Stabilization and quantitative analysis of fecapentaenes in human feces, using synthetic fecapentaene-12.
    Kleinjans JC; Pluijmen MH; Hageman GJ; Verhagen H
    Cancer Lett; 1989 Jan; 44(1):33-7. PubMed ID: 2917340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative HPLC analysis of the level of fecapentaenes and their precursors in human feces by a chemical conversion method.
    Kivits GA; de Boer BC; Nugteren DH; van der Steeg M; Vertegaal LB; van der Gen A
    J Nat Prod; 1990; 53(1):42-9. PubMed ID: 2348203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poly TMS and poly acetate derivatives for fingerprinting polyenes by NMR.
    Swami MB; Sastry MK; Nirgudkar AG; Nanda RK
    Hindustan Antibiot Bull; 1983; 25(3-4):101-14. PubMed ID: 6674274
    [No Abstract]   [Full Text] [Related]  

  • 6. Correlation of HPLC retention times with structure and functional group of macrolide polyenes.
    Swami MB; Sastry MK; Nirgudkar AG; Nanda RK
    Hindustan Antibiot Bull; 1983; 25(3-4):81-100. PubMed ID: 6674277
    [No Abstract]   [Full Text] [Related]  

  • 7. Fecapentaene excretion: aspects of excretion in newborn infants, children, and adult normal subjects and in adults maintained on total parenteral nutrition.
    Block JB; Dietrich MF; Leake R; Laidlaw SA; Vinton NE; Kopple JD
    Am J Clin Nutr; 1990 Apr; 51(4):698-704. PubMed ID: 2108580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation of 8-hydroxydeoxyguanosine in DNA treated with fecapentaene-12 and -14.
    Shioya M; Wakabayashi K; Yamashita K; Nagao M; Sugimura T
    Mutat Res; 1989 Mar; 225(3):91-4. PubMed ID: 2927433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and quantitative distribution of eight analogues of naturally occurring fecapentaenes in human feces by high-performance liquid chromatography.
    de Kok TM; ten Hoor F; Kleinjans JC
    Carcinogenesis; 1991 Feb; 12(2):199-205. PubMed ID: 1995185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case-control study of colorectal cancer and fecapentaene excretion.
    Schiffman MH; Van Tassell RL; Robinson A; Smith L; Daniel J; Hoover RN; Weil R; Rosenthal J; Nair PP; Schwartz S
    Cancer Res; 1989 Mar; 49(5):1322-6. PubMed ID: 2917361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Method of chemical determination of fusarin C].
    Jiang YZ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1988 Feb; 10(1):72-4. PubMed ID: 2968184
    [No Abstract]   [Full Text] [Related]  

  • 12. Fecapentaene concentration and mutagenicity in 718 North American stool samples.
    Schiffman MH; Van Tassell RL; Andrews AW; Wacholder S; Daniel J; Robinson A; Smith L; Nair PP; Wilkins TD
    Mutat Res; 1989 Apr; 222(4):351-7. PubMed ID: 2649794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and structure elucidation of fecapentaenes-12, potent mutagens from human feces.
    Hirai N; Kingston DG; Van Tassell RL; Wilkins TD
    J Nat Prod; 1985; 48(4):622-30. PubMed ID: 4045474
    [No Abstract]   [Full Text] [Related]  

  • 14. The structure of cogomycin.
    Pozsgay V; Tamás J; Czira G; Wirthlin T; Lévai A
    J Antibiot (Tokyo); 1976 Apr; 29(4):472-6. PubMed ID: 931817
    [No Abstract]   [Full Text] [Related]  

  • 15. On distribution of different fecapentaenes, the fecal mutagens, in the human population.
    Baptista J; Bruce WR; Gupta I; Krepinsky JJ; van Tassell RL; Wilkins TD
    Cancer Lett; 1984 Apr; 22(3):299-303. PubMed ID: 6713371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of candicidin, levorin and trichomycin by means of high-performance liquid chromatography.
    Hansen SH; Thomsen M
    J Chromatogr; 1976 Jul; 123(1):205-11. PubMed ID: 985823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. General structure of "fecapentaenes"--the mutagenic substances in human faeces: a preliminary report.
    Bruce WR; Baptista J; Che T; Furrer R; Gingerich JS; Gupta I; Krepinsky JJ; Grey AA; Yates P
    Naturwissenschaften; 1982 Nov; 69(11):557-8. PubMed ID: 7155190
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro study on the effects of fecal composition on fecapentaene kinetics in the large bowel.
    de Kok TM; van Iersel ML; ten Hoor F; Kleinjans JC
    Mutat Res; 1993 Jun; 302(2):103-8. PubMed ID: 7684504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis and assay of polyene antifungal antibiotics. A review.
    Thomas AH
    Analyst; 1976 May; 101(1202):321-40. PubMed ID: 776034
    [No Abstract]   [Full Text] [Related]  

  • 20. Fecapentaenes and their precursors throughout the bowel--results of an autopsy study.
    Schiffman MH; Bitterman P; Viciana AL; Schairer C; Russell L; Van Tassell RL; Wilkins TD
    Mutat Res; 1988 May; 208(1):9-15. PubMed ID: 3367931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.